Patient online self-reporting of toxicity symptoms during chemotherapy

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3552-3561

  Basch, Ethan ^a   Artz, David ^a   Dulko, Dorothy ^a   Scher, Kevin ^a   Sabbatini, Paul ^a   Hensley, Martee ^a   Mitra, Nandita ^a   Speakman, John ^a   McCabe, Mary ^a   Schrag, Deborah ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CONSTIPATION; DIARRHEA; FATIGUE; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HOME CARE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; NAUSEA; ONLINE SYSTEM; OUTPATIENT; PAIN; PATIENT MONITORING; PRIORITY JOURNAL; SELF REPORT; VOMITING; ADOLESCENT; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; FEASIBILITY STUDY; FEMALE GENITAL TRACT TUMOR; MIDDLE AGED; PATHOLOGY; PATIENT PARTICIPATION; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; DRUG TOXICITY; FEASIBILITY STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INTERNET; MIDDLE AGED; ONLINE SYSTEMS; PATIENT PARTICIPATION; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 20644435368     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.275     Document Type: Article

References (36)

1. Fairclough DL: Design and Analysis of Quality of Life Studies in Clinical Trials. Boca Raton, FL, CRC Press, 2002
2. National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) version 3.0, June 10, 2003 update. http//ctep.cancer.gov/forms/ CTAEv3.pdf
3. Velikova G, Booth L, Smith AB, et al: Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. J Clin Oncol 22:714-724, 2004
4. Science Panel on Interactive Communication and Health: Wired for Health and Well-Being: The Emergence of Interactive Health Communication. Washington, DC, US Department of Health and Human Services, US Government Printing Office, April 1999
5. Robinson TN, Patrick K, Eng TR, et al: An evidence-based approach to interactive health communication: A challenge to medicine in the information age-Science Panel on Interactive Communication and Health. JAMA 280:1264-1269, 1998
6. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Patient-reported complications and follow-up treatment after radical prostatectomy: The National Medicare Experience-1988-1990 (updated June 1993). Urology 42:622-629, 1993
7. Velikova G, Wright P, Smith AB, et al: Self-reported quality of life of individual cancer patients: Concordance of results with disease course and medical records. J Clin Oncol 19: 2064-2073, 2001
8. Fromme EK, Eilers KM, Mori M, et al: How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol 22:3485-3490, 2004
9. Litwin MS, Lubeck DP, Henning JM, et al: Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol 159:1988-1992, 1998
10. Vogelzang NJ, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey-The Fatigue Coalition. Semin Hematol 34:4-12, 1997 (suppl 2)
11. Gwede CK, Johnson DJ, Daniels SS, et al: Assessment of toxicity in cooperative oncology clinical trials: The long and short of it. J Oncol Manag 11:15-21, 2002
12. Acquadro C, Berzon R, Dubois D, et al: Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6:522-531, 2003
13. Wiklund I: Assessment of patient-reported outcomes in clinical trials: The example of health-related quality of life. Fundam Clin Pharmacol 18:351-363, 2004
14. Fairclough DL: Patient reported outcomes as endpoints in medical research. Stat Methods Med Res 13:115-138, 2004
15. Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties, applications, and interpretation. Health Qual Life Outcomes 1:79, 2003
16. Cella DF, TulsKy DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
17. West Clinic: The patient care monitor system. http://www.westclinic.com/ monitors_ content.html#
18. Tannock IF, de Wit R, Berry WR, et al: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502-1512, 2004
19. Eton DT, Fairclough DL, CeIIa D, et al: Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: Results from Eastern Cooperative Oncology Group Study 5592. J Clin Oncol 21:1536-1543, 2003
20. Cella D: The Functional Assessment of Cancer Therapy-Lung and Lung Cancer Subscale assess quality of life and meaningful symptom improvement in lung cancer. Semin Oncol 31:11-15, 2004 (suppl 9)
21. Cella D, Peterman A, Hudgens S, et al: Measuring the side effects of taxane therapy in oncology: The functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 98:822-831, 2003
22. Seo PH, D'Amico AV, Clark JA, et al: Assessing a prostate cancer brachytherapy technique using early patient-reported symptoms: A potential early indicator for technology assessment? Clin Prostate Cancer 3:38-42, 2004
23. Wright EP, Selby PJ, Crawford M, et al: Feasibility and compliance of automated measurement of quality of life in oncology practice. J Clin Oncol 21:374-382, 2003
24. Mooney KH, Beck SL, Friedman RH, et al: Telephone-linked care for cancer symptom monitoring: A pilot study. Cancer Pract 10:147-154, 2002
25. Le PP, Kohane IS, Weeks JC. Using a pen-based computer to collect health-related quality of life and utilities information. Proc 19th Annu Symp Comput Appl Med Care 1995:839-843
26. Nielsen//NetRatings, Inc: Internet Utilization Report, March 18, 2004: Three out of four Americans have access to the Internet, online population surges past 200 million mark for the first time. http://direct.www.nielsen/ netratings .com/pr/pr_040318.pdf
27. Velikova G, Wright EP, Smith AB, et al: Automated collection of quality-of-life data: A comparison of paper and computer touch-screen questionnaires. J Clin Oncol 17:998-1007, 1999
28. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
29. Rabin R, de Charro F: EQ-5D: A measure of health status from the EuroQol Group. Ann Med 33:337-343, 2001
30. Johnson JA, Coons SJ, Ergo A, et al: Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13:421-433, 1998
31. Mair F, Whitten P: Systematic review of studies of patient satisfaction with telemedicine. BMJ 320:1517-1520, 2000
32. Litwin MS, McGuigan KA: Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol 17:2882-2888, 1999
33. Goldberg RM, Sargent DJ, Morton RF, et al: Early detection of toxicity and adjustment of ongoing clinical trials: The history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program. J Clin Oncol 20:4591-4596, 2002
34. Sargent DJ, Goldberg RM, Mahoney MR, et al: Rapid reporting and review of an increased incidence of a known adverse event. J Natl Cancer Inst 92:1011-1013, 2000
35. Bjorner JB, Kosinski M, Ware JE Jr: The feasibility of applying item response theory to measures of migraine impact: A re-analysis of three clinical studies. Qual Life Res 12:887-902, 2003
36. Ware JE Jr, Kosinski M, Bjorner JB, et al: Applications of computerized adaptive testing (CAT) to the assessment of headache impact. Qual Life Res 12:935-952, 2003